Northsight Capital Appoints CEO
This article was originally published in Scrip
Northsight Capital Inc. has appointed John B. Hollister CEO. Hollister has over 25 years of commercial management and fundraising experience and held roles at various companies including SmithKline Beecham and Amgen, where he was director and global commercial leader in oncology. Most recently he was CEO and director of NEMUS Bioscience and previously was CEO and chair of medical device company, EGG Spectrum International. He was also senior vice-president for a diagnostic company, Tethys Bioscience.
Register for our free email digests: